全文获取类型
收费全文 | 31384篇 |
免费 | 3137篇 |
国内免费 | 839篇 |
专业分类
耳鼻咽喉 | 110篇 |
儿科学 | 588篇 |
妇产科学 | 510篇 |
基础医学 | 3523篇 |
口腔科学 | 468篇 |
临床医学 | 3068篇 |
内科学 | 7065篇 |
皮肤病学 | 519篇 |
神经病学 | 621篇 |
特种医学 | 752篇 |
外国民族医学 | 5篇 |
外科学 | 3557篇 |
综合类 | 4353篇 |
现状与发展 | 4篇 |
预防医学 | 1452篇 |
眼科学 | 267篇 |
药学 | 3532篇 |
20篇 | |
中国医学 | 3332篇 |
肿瘤学 | 1614篇 |
出版年
2024年 | 122篇 |
2023年 | 676篇 |
2022年 | 1093篇 |
2021年 | 1441篇 |
2020年 | 1390篇 |
2019年 | 1340篇 |
2018年 | 1254篇 |
2017年 | 1341篇 |
2016年 | 1341篇 |
2015年 | 1249篇 |
2014年 | 2121篇 |
2013年 | 3226篇 |
2012年 | 1811篇 |
2011年 | 1975篇 |
2010年 | 1423篇 |
2009年 | 1460篇 |
2008年 | 1377篇 |
2007年 | 1402篇 |
2006年 | 1264篇 |
2005年 | 1042篇 |
2004年 | 891篇 |
2003年 | 708篇 |
2002年 | 656篇 |
2001年 | 530篇 |
2000年 | 461篇 |
1999年 | 435篇 |
1998年 | 403篇 |
1997年 | 314篇 |
1996年 | 289篇 |
1995年 | 300篇 |
1994年 | 232篇 |
1993年 | 223篇 |
1992年 | 194篇 |
1991年 | 149篇 |
1990年 | 163篇 |
1989年 | 115篇 |
1988年 | 101篇 |
1987年 | 104篇 |
1986年 | 109篇 |
1985年 | 98篇 |
1984年 | 106篇 |
1983年 | 67篇 |
1982年 | 105篇 |
1981年 | 73篇 |
1980年 | 50篇 |
1979年 | 33篇 |
1978年 | 32篇 |
1977年 | 24篇 |
1976年 | 17篇 |
1975年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
《Journal of infection and chemotherapy》2022,28(4):587-590
A 37-year-old man developed right ankle pain and swelling six days after being diagnosed with coronavirus disease (COVID-19). Despite conservative treatment, his ankle symptoms persisted. Magnetic resonance imaging and computed tomography showed synovial hypertrophy and bone erosion in the ankle. Following arthroscopic synovectomy, performed 69 days after the COVID-19 diagnosis, the pain improved significantly. The clinical course was consistent with that of reactive arthritis following severe acute respiratory syndrome coronavirus 2 infection. The pathological findings resembled rheumatoid nodules. The bone erosion may have originated from the inflammatory pathway, which resembles the mechanism of rheumatoid arthritis. 相似文献
5.
Tofacitinib is an immunosuppressive and disease-modifying therapy in rheumatoid arthritis. It may result in many infections flaring up. It is important to take precautions of all kinds (cardiovascular, malignancy, infections etc.) before starting tofacitinib. In this article, we have highlighted important steps where we need to take precautions before starting tofacitinib. 相似文献
6.
Omar Abdel-Rahman 《Clinical genitourinary cancer》2019,17(2):e329-e338
Background
The objective of the study was to evaluate the outcomes of clinically localized prostate cancer treated with prostatectomy versus radiation therapy within the context of a prospective prostate cancer screening study.Patients and Methods
Within the PLCO (Prostate, Lung, Colorectal, and Ovary) trial, patients who were diagnosed with clinically localized prostate cancer and subsequently received treatment with prostatectomy or radiation therapy (with or without hormonal treatment) were included. Univariate and multivariate Cox regression analyses were then performed to determine factors affecting overall and prostate cancer-specific survival. Factors with P < .05 in univariate analysis were included in the multivariate analysis.Results
A total of 3953 patients were included in the current analysis. These included 2044 patients treated with prostatectomy and 1909 patients treated with radiation therapy with or without hormonal treatment. In an adjusted multivariate analysis for factors affecting overall survival, prostatectomy was associated with better overall survival compared with radiation therapy (hazard ratio, 0.548; 95% confidence interval [CI], 0.440- 681; P < .001). Likewise, in an adjusted multivariate analysis for factors affecting prostate cancer-specific survival, prostatectomy was associated with better prostate cancer-specific survival compared with radiation therapy (hazard ratio, 0.485; 95% CI, 0.286- 0.822; P = .007). Similar findings were found with propensity score matching and repeating the same analyses on the post-matching cohort.Conclusion
Prostatectomy seems to predict better overall and prostate cancer-specific survival compared with radiation therapy among patients with clinically localized prostate cancer diagnosed within the PLCO trial. 相似文献7.
8.
9.
10.